Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy

By Cookson M.S.   Fleshner N.E.   Soloway S.M.   Fair W.R.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 887-893

Elsevier

Access to resources Recommend Favorite

Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone?

By Lee W.R.   Hanlon A.   Hanks G.E.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 704-707

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen to predict outcome of external beam radiation for prostate cancer: walter reed army medical center experience 1988-1995 1

By Preston D.M.   Bauer J.J.   Connelly R.R.   Sawyer T.   Halligan J.   Leifer E.S.   McLeod D.G.   Moul J.W.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

Specific T Cell Recognition of Peptides Derived from Prostate-specific Antigen in Patients with Prostate Cancer

By Alexander R.B.   Brady F.   Leffell M.S.   Tsai V.   Celis E.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 150-157

Elsevier

Access to resources Recommend Favorite

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)

By Aus Gunnar   Becker Charlotte   Lilja Hans   Khatami Ali   Pihl Carl-Gustaf   Hugosson Jonas  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 466-470

Informa Healthcare

Access to resources Recommend Favorite